Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Micro-X Ltd. ( (AU:MX1) ) has issued an update.
Micro-X Ltd. has announced a rescheduled Investor Conference Call on February 13, 2025, where CEO Kingsley Hall will discuss the company’s activities, revised strategy, and business outlook. The company is a leader in cold cathode x-ray technology and is advancing its market presence with a focus on expanding its US business and developing new applications in health and security sectors. The announcement highlights Micro-X’s ongoing projects including contracts with the US Department of Homeland Security and a government-funded brain CT imager project, emphasizing its commitment to innovative solutions in the industry.
More about Micro-X Ltd.
Micro-X Limited is an ASX listed high-tech company specializing in the development and commercialization of innovative x-ray products for global health and security markets. It utilizes proprietary cold cathode, carbon nanotube emitter technology to produce x-ray products that are smaller, lighter, and require less power, enhancing mobility and usability. The company operates a fully integrated design and production facility in Adelaide, Australia, and is expanding its technical and commercial presence in the US, with products spanning healthcare, military, and security applications.
YTD Price Performance: -7.14%
Average Trading Volume: 488,047
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$45.53M
Learn more about MX1 stock on TipRanks’ Stock Analysis page.